Dxcover
PrivateLast Round
VC Round
Feb 3, 2025
Total Funding Raised
$21.95M
Company Overview
Dxcover operates in Healthcare & Life Sciences and is based in Glasgow. Its latest recorded funding round was a VC Round in February 2025.
Dxcover is a clinical-stage diagnostics company that provides a liquid biopsy platform using infrared spectroscopy and artificial intelligence for the early detection of multiple cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dxcover Comparables
Compare Dxcover with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| CanSense | 84% | |
| Oncodea | 83% | |
| Elypta | 80% |
For institutional investors. Book with your work email.
Dxcover Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 3, 2025 | ||||
| VC Round | Feb 5, 2024 | ||||
| Grant | Feb 1, 2023 | ||||
| Series A | Feb 1, 2023 | ||||
| Seed | Mar 4, 2021 | ||||
Seed | Sep 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dxcover Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| University of Strathclyde | VC Round, Seed, Series A |
| Mercia Asset Management | Series A |
| Eos Advisory | Seed, VC Round, Series A |
| European Innovation Council Fund | Grant |
| Alba Equity | Seed |
| Social Investment Scotland (SIS) Ventures | VC Round, Seed, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 26, 2025
Added ESMO, a medical society, as a customer.
- Nov 26, 2025
Added Life Sciences Awards, a media/events startup, as a customer.
For institutional investors. Book with your work email.
Dxcover Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dxcover's valuation, stock price, and market status.
Is Dxcover a public or private company?
Dxcover is a private company.
What is the current stock price of Dxcover?
Dxcover is a private company, so its shares have no public market price. Caplight tracks Dxcover's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dxcover worth (valuation)?
Valuation information for Dxcover is not publicly available.
Can I buy Dxcover stock?
Dxcover shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dxcover's last funding round?
Dxcover's most recent funding round was VC Round on February 3, 2025.
Who are the main investors in Dxcover?
Key investors in Dxcover include Eos Advisory, Mercia Ventures.
Will Dxcover IPO soon?
No public IPO plans have been announced for Dxcover.
How can I track Dxcover secondary market activity?
Caplight tracks bids, offers, and trades in Dxcover's shares on secondary markets.